Can Pheochromocytoma Cause Anemia?
Yes, pheochromocytoma can cause anemia, though this is an uncommon and atypical presentation that occurs primarily through microangiopathic hemolytic anemia (MAHA) as a paraneoplastic syndrome, particularly in malignant cases.
Mechanism and Clinical Context
While the major clinical guidelines for pheochromocytoma management 1, 2 focus on the classic triad of hypertension, headaches, palpitations, and sweating, they do not specifically address anemia as a presenting feature. However, recent case reports demonstrate that anemia can occur through specific pathophysiologic mechanisms:
Microangiopathic Hemolytic Anemia (MAHA)
The most well-documented mechanism is MAHA, where:
- Uncontrolled catecholamine-induced hypertension causes endothelial damage in microscopic blood vessels
- Red blood cells fragment as they pass through damaged capillaries, leading to hemolysis 3, 4
- This presentation is most commonly associated with malignant pheochromocytoma with metastatic disease 3
- Can be severe enough to require multiple blood transfusions 4
Direct Tumor Effects
Anemia may also occur as:
- A presenting symptom in bladder pheochromocytomas without typical hypertensive features 5
- Part of a broader paraneoplastic syndrome in metastatic disease 3
Clinical Recognition
When evaluating a patient with unexplained anemia, consider pheochromocytoma if:
- Anemia is accompanied by hypertensive crisis or resistant hypertension
- Evidence of hemolysis (elevated LDH, low haptoglobin, schistocytes on peripheral smear)
- Renal dysfunction develops concurrently 4
- Systemic symptoms include weight loss, abdominal pain, or unexplained fever 6, 7
- Imaging reveals an adrenal or extra-adrenal mass
Important Caveats
Anemia is NOT a typical screening indication: The established guidelines 8, 9, 2 recommend screening for pheochromocytoma based on hypertension patterns, catecholamine excess symptoms, genetic syndromes, or incidental adrenal masses—not anemia alone
Consider malignancy: When anemia (particularly MAHA) is present with pheochromocytoma, strongly suspect malignant disease with metastases 3
Life-threatening presentation: MAHA with pheochromocytoma can progress rapidly to multi-organ failure including acute renal failure and respiratory failure 4, requiring immediate intensive care management
Diagnostic Approach When Suspected
If pheochromocytoma is suspected in a patient with anemia:
- Measure plasma free metanephrines and normetanephrines (highest sensitivity 97-100%) 1, 2
- Obtain cross-sectional imaging (CT or MRI) of abdomen/pelvis 1, 2
- Evaluate for hemolysis markers if MAHA suspected
- Refer to specialized endocrinology/hypertension center, especially if biochemical tests are positive 8, 9
Bottom line: While anemia is a rare and atypical manifestation of pheochromocytoma rather than a classic presenting feature, its presence—particularly as MAHA—should raise concern for malignant disease and warrants urgent evaluation and management.